Year: 2024

HF Foods Group Inc. Names Felix Lin Chief Executive Officer

Written by Customer Service on December 19, 2024. Posted in Public Companies.

HF Foods Group Inc. Names Felix Lin Chief Executive OfficerHF Foods Group Inc. Names Felix Lin Chief Executive OfficerSeasoned HF Foods Executive with Deep Industry Relationships and Knowledge of Food Distribution Business Additional Appointments Made to People & Technology and Distribution Roles as HF Foods Continues to Make Progress on Strategic Transformation Plan LAS VEGAS, Dec. 19, 2024 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a leading food distributor to Asian restaurants across the United States, announced today that its Board of Directors has appointed Felix Lin as permanent Chief Executive Officer (CEO), effective January 1, 2025. Mr. Lin had previously served as President and Chief Operating Officer (COO) and was appointed to the additional role of Interim CEO...

OPTIMUM BANKHOLDINGS TRANSFERS LISTING OF COMMON STOCK TO THE NYSE AMERICAN

Written by Customer Service on December 19, 2024. Posted in Public Companies.

Fort Lauderdale, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) — OptimumBank Holdings, Inc. (NASDAQ: OPHC) (“OptimumBank” or the “Company”) today announced today that it is transferring the listing of its common stock to the NYSE American from The Nasdaq Stock Market LLC (“Nasdaq”). OptimumBank’s common stock is expected to begin trading on the NYSE American on December 31, 2024, under the ticker symbol of “OPHC.” The Company expects its common stock to continue to trade on Nasdaq until the close of the market on December 30, 2024. “We are excited to announce our new listing on the NYSE American. We believe this strategic move will help us increase the liquidity and visibility of our common stock and company as we join many other successful banks and companies, such as Strawberry Fields REIT, Inc. (STRW), in trading on the NYSE American,”...

Form 8.3 – Equipmake Holdings plc GB00BMBVXB73 – Octopus Investments

Written by Customer Service on December 19, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Equipmake Holdings plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing...

Heritage Distilling Company Strengthens Senior Leadership Team with Key Appointments to Accelerate Next Stage of Growth and Innovation

Written by Customer Service on December 19, 2024. Posted in Public Companies.

Expands Executive Team and Board of Directors with Former Starbucks COO Troy Alstead as a Director and Andrew Varga as a Director and Strategic Consultant – Chief Revenue Officer GIG HARBOR, Wash., Dec. 19, 2024 (GLOBE NEWSWIRE) — Heritage Distilling Company, Inc. (“HDC” or “Heritage”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, announced today two key appointments to its executive leadership and Board of Directors. These include Troy Alstead, a seasoned global executive and former COO of Starbucks Corporation, to its Board of Directors, and Andrew Varga, a leading spirits marketer and advertiser with more than four decades in the adult beverage industry, to lead Heritage’s business development initiatives as a strategic consultant and Chief Revenue Officer, as well as to serve as a Director. Founded...

HawkSearch Introduces GenAI-Powered PDF Data Capture Feature

Written by Customer Service on December 19, 2024. Posted in Public Companies.

WOBURN, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of AI-driven marketing technology, has announced a new Smart Response feature for HawkSearch that analyzes PDF content and delivers specific answers to user queries. The innovation includes tools for extracting content from large PDF repositories and using Generative AI (GenAI) to create helpful search features such as thumbnails of PDFs, summaries of pages within each PDF, and extraction of other important metadata such as file names and categorization. PDF Data Capture is a further example of HawkSearch’s focus on GenAI capabilities within its Smart Response suite. This innovation reinforces HawkSearch’s commitment to enhancing user experiences with advanced AI-driven tools. By providing detailed responses in addition to search...

YORVIPATH® (Palopegteriparatide) Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in Adults

Written by Customer Service on December 19, 2024. Posted in Public Companies.

COPENHAGEN, Denmark, Dec. 19, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as TransCon PTH) is now commercially available by prescription in the United States. YORVIPATH is a prodrug of parathyroid hormone (PTH [1-34]), administered once-daily, designed to provide continuous exposure to active PTH over the 24-hour dosing period. It is the first and only medicine approved by the U.S. Food & Drug Administration (FDA) for the treatment of hypoparathyroidism in adults. “Members of our community have shared so many stories of positive changes in their lives while participating in clinical trials of YORVIPATH,” said Patty Keating, Executive Director of the HypoPARAthyroidism Association. “We are thrilled that YORVIPATH is now available in the United States,...

Matt Carey to Lead Business Development and Delivery at Syntec Optics (Nasdaq: OPTX)

Written by Customer Service on December 19, 2024. Posted in Public Companies.

ROCHESTER, NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) — Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical products to advanced technology defense, biomedical, and communications equipment manufacturers, today announced the appointment of Matt Carey to head Business Development and Delivery. Having worked at Syntec Optics previously and returning, Carey brings a wealth of experience and a deep understanding of the Company’s engineering, customer interaction, and operations. In this newly created role, he will oversee the customer sales/program management, engineering, order fulfillment, and shipping teams, fostering a collaborative environment to drive innovation and ensure seamless customer service.Carey’s career at Syntec Optics spans nearly eight years, during...

Applied Optoelectronics Announces Entry into Exchange Transactions for 2026 Notes and Pricing of a Concurrent Registered Direct Offering

Written by Customer Service on December 19, 2024. Posted in Dividend Reports And Estimates.

SUGAR LAND, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI,” “we,” “us” or “our”) announced today that it has entered into transactions with holders (the “Noteholders”) of its 5.25% Convertible Senior Notes due 2026 (the “2026 Notes”) to exchange approximately $76.7 million principal amount of the 2026 Notes for (i) approximately $125 million aggregate principal amount of 2.75% Convertible Senior Notes due 2030 (the “2030 Notes”), (ii) approximately 1,487,874 shares of our common stock (the “Exchange Shares”) and (iii) approximately $89.6 thousand in cash representing accrued interest on the 2026 Notes and the value of fractional shares (such transactions, collectively, the “Exchanges”). The 2030 Notes will be our senior, unsecured obligations and will be equal in right of payment with...

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on December 19, 2024. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (NASDAQ: LAB) today announced its President and Chief Executive Officer, Michael Egholm, PhD, will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference taking place on January 13th – 16th at the Westin St. Francis Hotel in San Francisco, CA. Dr. Egholm’s corporate presentation will be held on January 16th, 2024, at 9:45 a.m. PT. A live audio webcast will be available to investors and other interested parties by accessing the Investor Relations page of the Company’s website at Events & Presentations. A recording will be archived and available on the Standard BioTools Investor Relations page at investors.standardbio.com. About Standard BioTools Inc. Standard BioTools Inc. (Nasdaq: LAB), the parent company of SomaLogic...

illumin Announces TSX Acceptance of Normal Course Issuer Bid

Written by Customer Service on December 19, 2024. Posted in Public Companies.

TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX:ILLM) (OTCQB:ILLMF) (“illumin” or “Company”) announced today that it has received approval from the Toronto Stock Exchange (“TSX“) to proceed with a normal course issuer bid (“NCIB“). Under the NCIB, the Company may purchase for cancellation up to 3,914,167 common shares of the Company (the “Shares“). As at December 10, 2024, illumin had 50,954,061 Shares issued and outstanding. As such, the maximum number of shares that may be purchased under the NCIB represents approximately 10% of illumin’s public float as at December 10, 2024, being 3,914,167 Shares. The Company’s average daily trading volume (“ADTV”) between June 1, 2024 and November 30, 2024 was 50,073 Shares and the daily purchase limit, being 25% of ADTV, is 12,518 Shares....

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals